Data / Form D filings / REGENTIS BIOMATERIALS LTD.
REGENTIS BIOMATERIALS LTD.: Form D filing
REGENTIS BIOMATERIALS LTD., a biotechnology company in Herzliya, Israel, filed a Form D with the SEC in 2026. The latest, on June 25, 2026, reports $6.5 million sold of a $6.5 million offering to 22 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 60 MEDINAT HAYEHUDIM STREET, Herzliya, Israel, 46766
- Phone
- +972 (9) 960-1917
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Israel
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(c)
- SEC identifier (CIK)
- 1912966
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jun 25, 2026 | New notice | $6,500,000 | $6,500,000 | 22 | Jun 17, 2026 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Ehud Geller | Executive Officer, Director | |
| Ori Gon | Executive Officer | |
| Arie Gordashnikov | Executive Officer | |
| Galit Reske | Executive Officer | |
| Jeff Dykan | Director | |
| Keith Valentine | Director | |
| Efraim Cohen-Arazi | Director | |
| Pini Ben-Elazar | Director | |
| Susan Alpert | Director |
Every Form D from the week of Jun 22, 2026 · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what REGENTIS BIOMATERIALS LTD. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.